Bartosz Hudzik: Do Elevated Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Otherwise Healthy Women?
Bartosz Hudzik, Associate Profesor at Medical University of Silesia, shared a post on LinkedIn about a recent article by Ask Tybjærg Nordestgaard et al, adding:
“Do elevated lipoprotein(a) levels predict long-term cardiovascular risk in otherwise healthy women?
A major prospective cohort study of 27,748 women followed for nearly 30 years provides important clarity:
- Lipoprotein(a) >30 mg/dL (≈75th percentile) was linked to higher risk of major cardiovascular events and coronary heart disease.
- Only very high levels (>120 mg/dL, ≈99th percentile) were associated with increased risk of ischemic stroke and cardiovascular death.
- Genetic carriers of the LPA rs3798220 variant also showed higher cardiovascular risk.
The takeaway:
- Very high lipoprotein(a) appears to be a meaningful long-term risk marker even among healthy women, strengthening the case for broader population screening strategies and earlier preventive intervention.
As precision prevention becomes central to cardiology, should Lp(a) testing become routine in midlife risk assessment?
Tagging colleagues advancing prevention science and lipid research.”
Title: Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a)
Authors: Ask Tybjærg Nordestgaard, Daniel Chasman, Vinayaga Moorthy, Jordan Kraaijenhof, Nancy Cook, I-Min Lee, Julie Buring, Paul Ridker
Read the Full Article on JAMA Cardiology
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 27, 2026, 18:19Trulee Cardona: Hemophilia Care in Uzbekistan and Why It Matters
-
Feb 27, 2026, 18:14Mohamed Sikkander Abdul Razak: Factor XIa Inhibitors Show Promise With Lower Bleeding Risk
-
Feb 27, 2026, 18:09Hariom Rajput: Early Recognition and Prevention of Deep Vein Thrombosis
-
Feb 27, 2026, 18:08Karen Fahey: What If the Blood Products You Rely On Weren’t Safe?
-
Feb 27, 2026, 17:46Perla Bandini: Whole-Exome Sequencing Unveils Suspected Primary Hemostasis Disorders
-
Feb 27, 2026, 17:44Ekaterina Balaian: Exploring Fostamatinib Use in APS Patients with Thrombocytopenia
-
Feb 27, 2026, 17:41Tagreed Alkaltham: Transfusion Reaction – Understanding Risk and Acting Early
-
Feb 27, 2026, 17:29Isabel Bär: A Novel Gene Therapy Strategy for Heterozygous VWD
-
Feb 27, 2026, 17:19Selma Turkovic: BTEDG Announces New Date for Wrong Blood in Tube Webinar